Sep 2026
Rhoifolin attenuates atopic dermatitis-like symptoms in mice by regulating PPARα-mediated NF-κB/NLRP3 inflammation and pyroptosis processes.
It is demonstrated that ROF exerts favorable inhibitory effects against AD-like inflammation both in vivo and in vitro, underscoring its potential as a viable therapeutic option for managing AD and other inflammatory cutaneous disorders.
Hui Li, Heng-Li Luo, Xin Zhang et al.
· Bioorganic chemistry (Print) · 0 citations